AIM Vaccine Co., Ltd., a leading PRC vaccine company, announced today that its independently developed mRNA RSV (respiratory syncytial virus) vaccine has recently been submitted for clinical trials to ...
The LNP-mRNA modality is a novel approach that uses lipid nanoparticles to deliver messenger RNA into cells. The mRNA acts as ...
There are two paths of the adaptive immune response: the humoral response that uses antibodies, and the cell-mediated response which uses cytotoxic T cells. Antibodies are small Y shaped proteins that ...
These anti-immune complex antibodies have not been studied in very much depth, especially in the context of HIV vaccination. Understanding these responses could lead to smarter vaccine designs and ...
Median 4-week preF IgG fold rise was 4.21; 61% of participants achieved seroconversion. (HealthDay News) — For immunocompromised individuals, antibody response to respiratory syncytial virus ...
Antibody-mediated immunity is crucial for preventing and limiting viral infections, and potent neutralizing antibodies could serve as potential therapeutic agents. In this review, we describe recent ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results